Drugs Made In America Acquisition (DMIIR) Total Non-Current Liabilities (2025)
Drugs Made In America Acquisition's (DMIIR) quarterly Total Non-Current Liabilities came in at $17.5 million in Q4 2025.
Drugs Made In America Acquisition (DMIIR) Total Non-Current Liabilities (2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has 1 years of Total Non-Current Liabilities data on file, last reported at $17.5 million in Q4 2025.
- On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $17.5 million in Q4 2025; TTM through Dec 2025 was $17.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $17.5 million, changed N/A from the prior year.
- Total Non-Current Liabilities for Q4 2025 stood at $17.5 million.
- Over the last five years, Total Non-Current Liabilities for DMIIR reached as high as $17.5 million in Q4 2025 and fell as low as $17.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 480.75 Mn | 480.75 Mn | - | - |
| 2 | Agriculture & Natural Solutions Acquisition | 393.29 Mn | 393.29 Mn | - | 29.40 Mn |
| 3 | Berto Acquisition | 314.56 Mn | 314.35 Mn | - | - |
| 4 | GP-Act III Acquisition | 313.66 Mn | 313.66 Mn | - | - |
| 5 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | - |
| 6 | Republic Digital Acquisition | 310.50 Mn | 309.63 Mn | - | - |
| 7 | Siddhi Acquisition Corp (Cayman Islands) | 288.97 Mn | 288.97 Mn | - | - |
| 8 | K&F Growth Acquisition | 283.42 Mn | 283.42 Mn | - | - |
| 9 | Bold Eagle Acquisition | 275.29 Mn | 275.29 Mn | - | - |
| 10 | Drugs Made In America Acquisition | - | - | - | 17.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.50 Mn |